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Colorectal cancer is one of the most frequent in the Brazilian population. The 
available forms of treatment are associated with a high risk of complications, 
thus highlighting the need to elaborate new therapeutic strategies. Intake of 
probiotics may be a viable therapeutical option for the treatment of 
colorectal cancer. The goal of the present study was to review the use of 
probiotics in the treatment of colorectal cancer induced by 1,2-
dimethylhydrazine in rats. This is a literature review of articles published 
between 1999 and 2017 in the pubmed database, with the descriptors: 
"probiotics", "colorectal cancer" and "dimethylhydrazine". Found 23 articles 
within the search inclusion criteria. The probiotic strains studied showed 
differences in type, concentration and mode of intervention. The use of 
probiotics was mostly isolated or associated with prebiotic fibers. The main 
benefits were: reduction of incidence and size of tumors, modulation of the 
microbiota in a positive way, better anti-inflammatory response and lower 
DNA damage. The need for more studies to provide more complete and 
delineated data, with mixtures of strains and specific amounts, provides more 
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